TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
TEVA PHARMACEUTICAL INDUSTRIES LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$41.31−0.19 (-0.46%)
Close on Oct 19, 2026
- Market cap
- $48.13B
- P/E (TTM)
- 68.9
- Dividend yield
- –
SEC filings
40 of Teva Pharmaceutical Industries's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 16, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 11, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2026 | Sep 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2026 | Sep 3, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | May 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 28, 2026 | Mar 31, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 11, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2025 | Jan 29, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Jul 31, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2024 | Jul 31, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2024 | Jun 25, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2024 | Jun 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 18, 2024 | Apr 18, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2024 | Apr 16, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 12, 2024 | SEC EDGAR |